ArticleFrontiers in genetics2025
EPI-DynFusion: enhancer-promoter interaction prediction model based on sequence features and dynamic fusion mechanisms.
Article in Frontiers in genetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Epigenetic research methods and animal models for intervertebral disc degeneration (Review).Molecular medicine reports · 2026Review
- DcSE: an improved densenet with enhanced attention fusion for super-enhancer prediction.BMC genomics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Enhancer-promoter interactions (EPIs) play a vital role in the regulation of gene expression. Although traditional wet-lab methods provide valuable insights into EPIs, they are often constrained by high costs and limited scalability. As a result, the development of efficient computational models has become essential. However, many current deep learning and machine learning approaches utilize simplistic feature fusion strategies, such as direct averaging or concatenation, which fail to effectively model complex relationships and dynamic importance across features. This often results in suboptimal performance in challenging biological contexts. Methods: To address these limitations, we propose a deep learning model named EPI-DynFusion. This model begins by encoding DNA sequences using pre-trained DNA embeddings and extracting local features through convolutional neural networks (CNNs). It then integrates a Transformer and Bidirectional Gated Recurrent Unit (BiGRU) architecture with a Dynamic Feature Fusion mechanism to adaptively learn deep dependencies among features. Furthermore, we incorporate the Convolutional Block Attention Module (CBAM) to enhance the model's ability to focus on informative regions. Based on this core architecture, we develop two variants: EPI-DynFusion-gen, a general model, and EPI-DynFusion-best, a fine-tuned version for cell line-specific data. Results: We evaluated the performance of our models across six benchmark cell lines. The average area under the receiver operating characteristic curve (AUROC) scores achieved by the specific, generic, and best models were 94.8%, 95.0%, and 96.2%, respectively. The average area under the precision-recall curve (AUPR) scores were 81.2%, 71.1%, and 83.3%, respectively, demonstrating the superior performance of the fine-tuned model in the precision-recall space. These results confirm that the proposed fusion strategies and attention mechanisms contribute to significant improvements in performance. Discussion: In conclusion, EPI-DynFusion presents a robust and scalable framework for predicting enhancer-promoter interactions solely based on DNA sequence information. By addressing the limitations of conventional fusion techniques and incorporating attention mechanisms alongside sequence modeling, our method achieves state-of-the-art performance while enhancing the interpretability and generalizability of enhancer-promoter interaction prediction tasks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.